RhoVac | Business Coach | Oncology | Pharma partnering | Deal making | Communication

RhoVac was an R&D company developing a unique prostate cancer therapy, targeting metastatic cells to prevent cancer recurrence and progression after primary tumor therapy.

RhoVac obtained a Horizon 2020 (EIC Accelerator) grant and hereby obtained access to Business Coaching. RhoVac’s CEO selected me as Business Coach. Each of the sessions were prepared and researched to cover the following aspects in CEO-dialogue:

Value proposition for the clinical applications and patient types of lead drug candidate

External communication channels and messages

Key value drivers for big pharma partners

Extract maximum value from engagement of transaction advisor

Identify trade-offs between deal type alternatives

Identify and apply “irrational factors” to enhance deal making

Identify alternatives to unattractive deal offers

Identify multi-indication strategies to increase drug asset value

How to break challenging news to stakeholders

Testimonial is available from RhoVac’s CEO.